SE7909106L - Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika - Google Patents

Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika

Info

Publication number
SE7909106L
SE7909106L SE7909106A SE7909106A SE7909106L SE 7909106 L SE7909106 L SE 7909106L SE 7909106 A SE7909106 A SE 7909106A SE 7909106 A SE7909106 A SE 7909106A SE 7909106 L SE7909106 L SE 7909106L
Authority
SE
Sweden
Prior art keywords
aryltrifluoretanols
therapeutics
prepare
new
pharmaceutical compositions
Prior art date
Application number
SE7909106A
Other languages
English (en)
Inventor
M Vincent
G Remond
J Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE7909106L publication Critical patent/SE7909106L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
SE7909106A 1978-11-03 1979-11-02 Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika SE7909106L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
SE7909106L true SE7909106L (sv) 1980-05-04

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7909105A SE7909105L (sv) 1978-11-03 1979-11-02 Farmaceutiska kompositioner pa basis av aryltrifluoretanol
SE7909106A SE7909106L (sv) 1978-11-03 1979-11-02 Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7909105A SE7909105L (sv) 1978-11-03 1979-11-02 Farmaceutiska kompositioner pa basis av aryltrifluoretanol

Country Status (27)

Country Link
US (2) US4285943A (sv)
JP (2) JPS5566510A (sv)
AR (2) AR223989A1 (sv)
AT (1) AT368483B (sv)
AU (1) AU527630B2 (sv)
BE (2) BE879786A (sv)
CA (2) CA1142087A (sv)
CH (2) CH647225A5 (sv)
DD (2) DD147048A5 (sv)
DE (2) DE2944293A1 (sv)
DK (2) DK461579A (sv)
EG (1) EG14114A (sv)
ES (1) ES485656A0 (sv)
FI (2) FI793444A (sv)
FR (1) FR2440353A1 (sv)
GB (2) GB2038802B (sv)
GR (2) GR68015B (sv)
IL (2) IL58620A (sv)
IT (2) IT7950715A0 (sv)
MA (2) MA18629A1 (sv)
NL (2) NL7908101A (sv)
NZ (2) NZ192021A (sv)
OA (2) OA06372A (sv)
PT (2) PT70408A (sv)
SE (2) SE7909105L (sv)
SU (1) SU925247A3 (sv)
ZA (2) ZA795870B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EP2396081B1 (en) 2009-02-16 2017-04-05 Nogra Pharma Limited Alkylamido compounds and uses thereof
MX364220B (es) 2012-02-09 2019-04-16 Nogra Pharma Ltd Metodos de tratamientos de fibrosis.
IN2014DN08157A (sv) 2012-04-18 2015-05-01 Nogra Pharma Ltd
WO2020161362A1 (en) 2019-02-08 2020-08-13 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
GR66480B (sv) * 1977-10-07 1981-03-24 Science Union & Cie

Also Published As

Publication number Publication date
CA1139763A (fr) 1983-01-18
JPS5566510A (en) 1980-05-20
BE879787A (fr) 1980-04-30
PT70407A (en) 1979-12-01
AU527630B2 (en) 1983-03-17
DE2944294A1 (de) 1980-05-08
MA18629A1 (fr) 1980-07-01
NZ192021A (en) 1982-09-07
EG14114A (en) 1983-03-31
AU5241679A (en) 1980-05-08
ZA795871B (en) 1980-10-29
OA06372A (fr) 1981-08-31
AR223989A1 (es) 1981-10-15
NL7908099A (nl) 1980-05-07
OA06373A (fr) 1981-08-31
JPS5566548A (en) 1980-05-20
SE7909105L (sv) 1980-05-04
DD151445A5 (de) 1981-10-21
GB2038802B (en) 1982-12-08
DE2944293A1 (de) 1980-05-08
DD147048A5 (de) 1981-03-18
IL58620A (en) 1982-12-31
GB2034587A (en) 1980-06-11
IL58620A0 (en) 1980-02-29
DK461579A (da) 1980-05-04
MA18628A1 (fr) 1980-07-01
GB2038802A (en) 1980-07-30
ZA795870B (en) 1980-10-29
BE879786A (fr) 1980-04-30
ES8101538A1 (es) 1980-12-16
US4285943A (en) 1981-08-25
FI793444A (fi) 1980-05-04
FI793445A (fi) 1980-05-04
CH647225A5 (fr) 1985-01-15
AT368483B (de) 1982-10-11
ES485656A0 (es) 1980-12-16
NL7908101A (nl) 1980-05-07
FR2440353A1 (fr) 1980-05-30
IT7950715A0 (it) 1979-10-31
AR223990A1 (es) 1981-10-15
GR68015B (sv) 1981-10-27
IL58621A0 (en) 1980-02-29
PT70408A (fr) 1979-12-01
NZ192020A (en) 1982-12-21
DK461679A (da) 1980-05-04
GB2034587B (en) 1983-02-09
US4404215A (en) 1983-09-13
SU925247A3 (ru) 1982-04-30
IT7950714A0 (it) 1979-10-31
CA1142087A (fr) 1983-03-01
ATA701679A (de) 1982-02-15
CH641043A5 (fr) 1984-02-15
GR69726B (sv) 1982-07-09

Similar Documents

Publication Publication Date Title
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
IT7823982A0 (it) Composizioni per il trattamento dei tessili.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NL7513370A (nl) Werkwijze voor de bereiding van farmaceutische samenstellingen onder toepassing van l-dopa of verbindingen daarvan.
IL58782A0 (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
NL171543B (nl) Met de hand bedienbare verstuiver.
DK147468C (da) Analogifremgangsmaade til fremstilling af 14-chlor- eller 13,14-didehydro-prostaglandinderivater
NL930052I2 (nl) 2,6-Dialkoxybenzamiden, werkwijze ter bereiding ervan, samenstellingen en deze verbindingen voor toepassing bij de behandeling van psychotische afwijkingen.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
SE7909106L (sv) Nya aryltrifluoretanoler, sett att framstella dessa samt deras anvendning som terapeutika
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NL7900913A (nl) Werkwijze voor het verbeteren van de consistentie van een gereconstitueerde instantpuree.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
ES485168A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica util para el tratamiento de la hipercolesteremia.
ES241316Y (es) Dispositivo ensanchador para el tratamiento de displasais dela cadera.
NL7603661A (nl) Werkwijze ter bereiding van desinfecteermiddelen.
FI800350A (fi) Dehydropeptider foerfarande foer framstaellning av dessa samt anvaendningen av dessa som laekemedel
IT7923367A0 (it) Procedimento per la preparazione di composti del tipo-indaco.
NO801613L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
IT7926493A0 (it) Impianto rotante per il trattamento di recipienti.
NO145135C (no) Analogifremgangsmaate ved fremstilling av den terapeutisk aktive forbindelse 3-cyan-n-(n,n-diemtylaminopropyl)-iminodibenzyl
IT7821264A0 (it) Composizione per il trattamento dell'asma.
IT7820129A0 (it) 2,4-diclorofenti-imidazolil-etanoni (oli), procedimento per la loro preparazione e loro impiego come prodotti medicinali.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7909106-2

Format of ref document f/p: F